Form 8-K - Current report:
SEC Accession No. 0001193125-24-199396
Filing Date
2024-08-13
Accepted
2024-08-13 07:16:04
Documents
15
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d864520d8k.htm   iXBRL 8-K 25789
2 EX-99.1 d864520dex991.htm EX-99.1 48055
6 GRAPHIC g864520g0813001701997.jpg GRAPHIC 3901
  Complete submission text file 0001193125-24-199396.txt   217615

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20240813.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20240813_lab.xml EX-101.LAB 19500
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20240813_pre.xml EX-101.PRE 12162
17 EXTRACTED XBRL INSTANCE DOCUMENT d864520d8k_htm.xml XML 3918
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 241198757
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)